KR100253046B1 - 고함량 이부프로펜 응집물의 제조방법(High content ibuprofen agglomerates and process to prepare them) - Google Patents

고함량 이부프로펜 응집물의 제조방법(High content ibuprofen agglomerates and process to prepare them) Download PDF

Info

Publication number
KR100253046B1
KR100253046B1 KR1019940700716A KR19940700716A KR100253046B1 KR 100253046 B1 KR100253046 B1 KR 100253046B1 KR 1019940700716 A KR1019940700716 A KR 1019940700716A KR 19940700716 A KR19940700716 A KR 19940700716A KR 100253046 B1 KR100253046 B1 KR 100253046B1
Authority
KR
South Korea
Prior art keywords
propionic acid
isobutylphenyl
weight
starch
ibuprofen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
KR1019940700716A
Other languages
English (en)
Korean (ko)
Inventor
죤 애트킨 그레이엄
드류 피터
레슬리 터너 죤
Original Assignee
아이.에이.호틴
더 부츠 캄파니 피엘씨
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 아이.에이.호틴, 더 부츠 캄파니 피엘씨 filed Critical 아이.에이.호틴
Application granted granted Critical
Publication of KR100253046B1 publication Critical patent/KR100253046B1/ko
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Cephalosporin Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
KR1019940700716A 1991-09-06 1992-08-25 고함량 이부프로펜 응집물의 제조방법(High content ibuprofen agglomerates and process to prepare them) Expired - Fee Related KR100253046B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9119052.0 1991-09-06
GB919119052A GB9119052D0 (en) 1991-09-06 1991-09-06 Pharmaceutical compositions
PCT/EP1992/001953 WO1993004676A1 (en) 1991-09-06 1992-08-25 High content ibuprofen agglomerates and process to prepare them

Publications (1)

Publication Number Publication Date
KR100253046B1 true KR100253046B1 (ko) 2000-05-01

Family

ID=10700981

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019940700716A Expired - Fee Related KR100253046B1 (ko) 1991-09-06 1992-08-25 고함량 이부프로펜 응집물의 제조방법(High content ibuprofen agglomerates and process to prepare them)

Country Status (16)

Country Link
US (1) US5512302A (enExample)
EP (1) EP0602112B1 (enExample)
JP (1) JP3444597B2 (enExample)
KR (1) KR100253046B1 (enExample)
AT (1) ATE353213T1 (enExample)
AU (1) AU655673B2 (enExample)
CA (1) CA2116956C (enExample)
CZ (1) CZ282271B6 (enExample)
DE (1) DE69233678T2 (enExample)
FI (1) FI107878B (enExample)
GB (1) GB9119052D0 (enExample)
IL (1) IL103005A (enExample)
IN (1) IN174169B (enExample)
RU (1) RU2123841C1 (enExample)
WO (1) WO1993004676A1 (enExample)
ZA (1) ZA926709B (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI101039B (fi) * 1992-10-09 1998-04-15 Eeva Kristoffersson Menetelmä lääkepellettien valmistamiseksi
DE19814256A1 (de) * 1998-03-31 1999-10-07 Asta Medica Ag Feste, schnellzerfallende Cetirizin-Formulierungen
HUP0104606A3 (en) * 1998-12-18 2003-01-28 Basf Ag A pharmaceutical mixture comprising a profen
US6726929B1 (en) 1998-12-18 2004-04-27 Basf Aktiengesellschaft Pharmaceutical mixture comprising a profen
US6251945B1 (en) * 1999-01-14 2001-06-26 Knoll Aktiengesellschaft Pharmaceutical mixture comprising a combination of a profen and other active compounds
DE19901692C2 (de) * 1999-01-18 2002-06-20 Gruenenthal Gmbh Verfahren zur Herstellung von Pellets mit einem Gehalt von bis zu 90 Gew.% eines pharmazeutischen Wirkstoffes
DE10003757A1 (de) * 2000-01-28 2001-08-02 Knoll Ag Ibuprofen-Wirkstoffzubereitung
RU2164796C1 (ru) * 2000-05-25 2001-04-10 Открытое акционерное общество "Химико-фармацевтический комбинат "Акрихин" Противогистаминное средство и способ его получения
US6962715B2 (en) * 2001-10-24 2005-11-08 Hewlett-Packard Development Company, L.P. Method and dosage form for dispensing a bioactive substance
US20040173147A1 (en) * 2001-06-07 2004-09-09 Figueroa Iddys D. Application of a bioactive agent to a delivery substrate
US20040173146A1 (en) * 2001-06-07 2004-09-09 Figueroa Iddys D. Application of a bioactive agent to a delivery substrate
DE10153934A1 (de) * 2001-11-06 2003-05-22 Basf Ag Verfahren zur Kristallisation von Profenen
GB0312419D0 (en) * 2003-05-30 2003-07-02 Boots Healthcare Int Ltd Use of a compound in the treatment of sleep disorders and the like, in providing refreshedness on waking and a method for the treatment of grogginess
RU2254854C2 (ru) * 2003-09-08 2005-06-27 Открытое акционерное общество "Акционерное курганское общество медицинских препаратов и изделий "Синтез" Анальгезирующий, жаропонижающий, противовоспалительный препарат и способ его получения
US20050203482A1 (en) * 2004-03-15 2005-09-15 Chinea Vanessa I. Pharmaceutical dispensing apparatus and method
US20050202051A1 (en) * 2004-03-15 2005-09-15 Chinea Vanessa I. Pharmaceutical vehicle
JP2008266270A (ja) * 2007-04-25 2008-11-06 Kowa Co イブプロフェン、トラネキサム酸及び糖アルコールを含有する固形製剤
MX383484B (es) 2014-11-17 2025-03-11 Epizyme Inc Método para tratar el cáncer.

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0298666A2 (en) * 1987-07-08 1989-01-11 American Home Products Corporation Spray dried ibuprofen compositions

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5240712A (en) * 1987-07-17 1993-08-31 The Boots Company Plc Therapeutic agents
US4837031A (en) * 1987-09-17 1989-06-06 Mallinckrodt, Inc. Compositions containing ibuprofen
US4911921A (en) * 1989-02-02 1990-03-27 Mallinckrodt, Inc. High ibuprofen content granulations
US5266723A (en) * 1989-05-16 1993-11-30 Medice, Ltd., Chem.-Pharm. Fabrik Putter Gmbh & Co. Kg Process for the preparation of optically active 2-aryl-alkanoic acids, especially 2-aryl-propionic acids
US5087454A (en) * 1990-07-30 1992-02-11 American Home Products Corporation Ibuprofen tablet
US5260337A (en) * 1992-07-29 1993-11-09 Merck & Co., Inc. Ibuprofen-muscle relaxant combinations
US5332834A (en) * 1992-12-02 1994-07-26 Hoechst Celanese Corporation Racemization of an enantomerically enriched α-aryl carboxylic acid

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0298666A2 (en) * 1987-07-08 1989-01-11 American Home Products Corporation Spray dried ibuprofen compositions

Also Published As

Publication number Publication date
ZA926709B (en) 1993-04-28
AU2487092A (en) 1993-04-05
EP0602112B1 (en) 2007-02-07
CZ49994A3 (en) 1994-07-13
DE69233678T2 (de) 2008-01-24
IL103005A (en) 1996-01-19
WO1993004676A1 (en) 1993-03-18
CA2116956C (en) 2002-07-16
FI941046A0 (fi) 1994-03-04
AU655673B2 (en) 1995-01-05
RU2123841C1 (ru) 1998-12-27
JP3444597B2 (ja) 2003-09-08
GB9119052D0 (en) 1991-10-23
FI107878B (fi) 2001-10-31
ATE353213T1 (de) 2007-02-15
FI941046A7 (fi) 1994-03-04
US5512302A (en) 1996-04-30
EP0602112A1 (en) 1994-06-22
IN174169B (enExample) 1994-10-01
IL103005A0 (en) 1993-01-31
JPH06510532A (ja) 1994-11-24
CA2116956A1 (en) 1993-03-18
CZ282271B6 (cs) 1997-06-11
DE69233678D1 (de) 2007-03-22

Similar Documents

Publication Publication Date Title
KR100253046B1 (ko) 고함량 이부프로펜 응집물의 제조방법(High content ibuprofen agglomerates and process to prepare them)
DE69231359T2 (de) Ibuprofen-salz enthaltende pharmazeutische zusammensetzung
TW579295B (en) Celecoxib compositions
DE60018040T2 (de) Polymorphische kristalline formen von celecoxib
EP1849459A1 (en) Ezetimibe compositions
US20050008691A1 (en) Bicalutamide compositions
RU2329789C2 (ru) ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ, СОДЕРЖАЩАЯ N-[(1-nБУТИЛ-4-ПИПЕРИДИНИЛ)МЕТИЛ]-3,4-ДИГИДРО-2Н-[1,3]ОКСАЗИНО [3,2-a]ИНДОЛ-10-КАРБОКСАМИД ИЛИ ЕГО СОЛЬ, И СПОСОБ ЕЕ ПОЛУЧЕНИЯ, ВКЛЮЧАЮЩИЙ СУХУЮ ГРАНУЛЯЦИЮ
CZ20021839A3 (cs) Rozmělněná forma (S)-2-ethoxy-3-(4-(2-(4-methansulfonyloxyfenyl)ethoxy)fenyl)propanové kyseliny
JP2023184662A (ja) イストラデフィリン製剤
KR20050039732A (ko) 이부프로펜 결정의 형성 방법
JP2001503734A (ja) カリウム、ナトリウムおよびトリスオキサプロジン塩医薬組成物
WO2005020979A1 (en) A process for the preparation of pharmaceutical compositions of nateglinide
AU2002244857B2 (en) Pharmaceutical product with reticulated crystalline microstructure
CN101972240B (zh) 莫达芬尼组合物
EP1776102A1 (en) Preparations of stable pharmaceutical compositions of nateglinide and processes for their preparation
AU2002244857A1 (en) Pharmaceutical product with reticulated crystalline microstructure
CA2544049A1 (en) Pharmaceutical formulation containing an ltb4 antagonist, method for the production thereof, and use thereof
WO2005117840A1 (en) Stable pharmaceutical compositions comprising pulverized granules of nateglinide of form b
EP1933826A1 (en) Method of production of fine-crystalline mixture containing non-steroid anti-inflammatory drug, fine-crystalline mixture obtainable by this method and solid pharmaceutical composition containing this mixture
EP0535269A1 (en) Pharmaceutical compositions containing thiazolidinedione derivatives
WO2017115284A1 (en) Novel co-crystal forms of agomelatine
HK1108280A (en) Ezetimibe compositions

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

A201 Request for examination
P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U12-oth-PR1002

Fee payment year number: 1

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

FPAY Annual fee payment

Payment date: 20030109

Year of fee payment: 4

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 4

LAPS Lapse due to unpaid annual fee
PC1903 Unpaid annual fee

St.27 status event code: A-4-4-U10-U13-oth-PC1903

Not in force date: 20040122

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

PC1903 Unpaid annual fee

St.27 status event code: N-4-6-H10-H13-oth-PC1903

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 20040122